Click Here to See if you Qualify. AI, automation, and robotics have created an exciting age of disruptive innovation. Companies worldwide invest in AI products and services to stay ahead of their competition. Therefore, investing in AI stocks is a great way to profit from this growth sector; AI stocks combine the excitement and promise of AI with the potential for sustainable returns. With AI-based technologies becoming more ubiquitous daily, AI stocks offer investors a chance to gain exposure to companies with AI and automation at their core.

The global pandemic has given us all an opportunity to pause for thought and take stock of what is and what is not important. More and more businesses are turning to AI to become more sustainable, smarter and to better react to changing market conditions, as well as to ensure health, safety and social impact of our planet. We need a future where you can do the things you love; live the life you deserve and take the time to grow with nature and nurture the things that inspire you to help others. From pandemic prevention and fighting cancer, to fighting hunger, wildlife conservation and boosting accessibility, this article will explore exactly how AI is doing well by doing good. AI use cases can help towards overall adaptation in preventing wildfires, diagnosing deadly diseases, mitigating risks posed in critical areas as well as predictive analysis and monitoring to make our planet more resilient in the near future.

What are the best robotics and artificial intelligence stocks to buy today? In this time of uncertainty characterized by volatile market movements, economic contraction, and spiraling unemployment, finding stocks to put your money into seems like an arduous task. Some investors might think that the stock market is acting irrationally and puzzled by the quick recovery of stock prices sin the end of March. Economic reality is that long-term real interest rates are negative, the Federal Reserve is flooding the market with cheap credit, and the current economic slowdown is temporary. This is the perfect environment to buy technology stocks which aren't negatively affected by the coronavirus induced lockdowns and economic slowdown.

We're now accustomed to seeing robots deployed after natural disasters and in areas of heavy contamination. A robotics team, after all, was the quiet hero of the Fukushima disaster cleanup. Disruptive technologies like robotics and AI are working hard to fight the spread of the virus. In fact, the coronavirus outbreak is bringing renewed attention to an idea many in the robotics sphere have been trumpeting for some time: telemedicine. I reached out to ROBO Global, an index, advisory, and research company in the robotics sphere, for insight.

Intuitive Surgical (NASDAQ: ISRG), with a virtual monopoly in minimally invasive robotic surgery, faces an influx of competition. Medtronic, Verb Surgical (owned by Alphabet) and CMR Surgical could all launch in the US in the next 18 months. For the first time, Intuitive Surgical could face not only a pause in new system purchases but in a worst case scenario real market share losses and downward pricing pressure in both systems and instruments.

Need to back up personal files outside your computer? Here's a breakdown on the type of hard drives you can choose from to save your important files. Various forms of automation are sweeping through the economy. The thought of machines doing human work and eliminating jobs is a big worry, but it's not all bad. Automation can be a force for good, and health care is an example. That's where Intuitive Surgical, the pioneer in robotic surgery, comes in.

About one month ago, the headlines flashed, 'Gujarat doctor makes history', crediting cardiac surgeon Dr Tejas Patel with conducting the world's first telerobotic surgery on a patient in Ahmedabad. Sitting 32 kilometres away from his patient, a middle-aged woman with a blocked artery at Apex Hospital, Dr Patel guided the robotic arms through a joystick to perform the coronary intervention. The surgery sounded rumblings of a shift in healthcare. Is robotics the way to go? When the trauma caused by incisions in traditional open surgeries started becoming a point of concern, laparoscopic surgeries started becoming popular, in the '90s.

For one 43-year-old Beijing patient, relief had seemed an impossible dream. His arm had been numb for 14 months and every hospital he went to gave him the same answer to his questions about a remedy. Surgeons told him that the risks of mass bleeding, stroke or even paralysis were too great with the delicate operation needed to fix the abnormalities in his spine and skull that were causing the condition. Then three years ago the patient met Tian Wei, a top spinal surgeon at Beijing's Jishuitan Hospital and an advocate of using robotics in medical operations. Tian and his team used a technology called the TiRobot system to create a 3D scan of the patient's torso and plot a surgical path to the affected area.

With greater investment from healthcare organisations and surgical robot technology about to become generic, the conditions are perfect for a boom in the surgical robotics market. But how can design engineers and technical medical staff ensure these new systems operate reliably and safely? Michele Windsor, global marketing manager at surgical robot battery manufacturer Accutronics, has a solution. While they may sometimes feel like a new medical technology, surgical robots have actually been around for several decades. The first robot system successfully conducted a neurosurgical biopsy in 1985, while the US Food and Drug Administration (FDA) approved its first surgical robot -- the da Vinci surgical system -- in 2000.

Like all everyday miracles of technology, the longer you watch a robot perform surgery on a human being, the more it begins to look like an inevitable natural wonder. Earlier this month I was in an operating theatre at University College Hospital in central London watching a 59-year-old man from Potters Bar having his cancerous prostate gland removed by the four dexterous metal arms of an American-made machine, in what is likely a glimpse of the future of most surgical procedures. The robot was being controlled by Greg Shaw, a consultant urologist and surgeon sitting in the far corner of the room with his head under the black hood of a 3D monitor, like a Victorian wedding photographer. Shaw was directing the arms of the remote surgical tool with a fluid mixture of joystick control and foot-pedal pressure and amplified instruction to his theatre team standing at the patient's side. The surgeon, 43, has performed a thousand of such procedures, which are particularly useful for pelvic operations; those, he says, in which you are otherwise "looking down a deep, dark hole with a flashlight".